Balaji Amines Ltd. News and Updates

Name: Latest research reports of Balaji Amines Ltd. authored by Edelweiss and published by - Trendlyne research reports.
Item: Balaji Amines Ltd.
Rating: 5
Author: Edelweiss

Keep track of all breaking news on Balaji Amines Ltd. from all sources in a single place.

Load latest

Balaji Amines Ltd.

06 Feb 2020

1411.40

-4.12%

Balaji Amines Ltd - Result Update Q3FY20

Buy: Balaji Amines Ltd.

Edelweiss

Balaji Amines Ltd's (BAL) Q3FY20 results were broadly in-line with our expectations.

Balaji Amines Ltd. is trading below all available SMAs

Balaji Amines Ltd.

20 Jan 2020

1411.40

-4.12%

Balaji Amines (Update): All eyes on the subsidiary. Maintain BUY

Buy: Balaji Amines Ltd.

Target

HDFC Securities

Given the (1) Uncertainty in the ramp up of BSCPL (2) Muted earnings growth prospect (3) Declining return ratios (ROE: 16.1/15.1/13.5%, RoIC: 22.5/21.7/18.8% in FY20E/21E/22E), we prefer Alkyl Amines over Balaji in the Amines space. Maintain BUY with a TP of Rs 490 (13x Dec-21E EPS). We visited Balaji Amines and its subsidiarys Solapur facility, which was followed by an interaction with Mr. Ram Reddy, the companys Managing Director.

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Balaji Amines Ltd.

17 Jan 2020

1411.40

-4.12%

Balaji Amines: Anti-dumping probe is just what the doctor ordered

Moneycontrol

NULL

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines Ltd.

28 Nov 2019

1411.40

-4.12%

Balaji Amines: Green clearance sets up the right pitch

Moneycontrol

NULL

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines share price rises 7% on environmental clearance for plant

Moneycontrol | 28 Nov 2019

Balaji Amines Ltd.

04 Nov 2019

1411.40

-4.12%

Balaji Amines Ltd - Result Update Q2FY20

Buy: Balaji Amines Ltd.

Edelweiss

Balaji Amines Ltd's Q2FY20 results were in-line with our expectations. Revenue came in at INR 227 crore on a consolidated basis, which was broadly similar to what was achieved in the prior quarter.

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines Ltd.

02 Nov 2019

1411.40

-4.12%

Balaji Amines (2QFY20): Strong volumes drive profitability. Maintain BUY

Buy: Balaji Amines Ltd.

Target

HDFC Securities

Owing to muted earnings growth prospects, and declining return ratios (ROE: 16.1/15.1/13.5%, RoIC: 22.5/21.7/18.8% in FY20E/21E/22E), we prefer Alkyl Amines over Balaji in the Amines space. We maintain BUY on BAL, post its above expectation performance in Q2FY20, with a TP of Rs 488 (13x Sep-21E EPS). Strong volume traction in high margin Specialty chemicals and Amines Derivatives coupled with benign RMC, amplified its operating performance.

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines Ltd.

30 Sep 2019

1411.40

-4.12%

BP Equities Balaji Amines Ltd. Management Meet Note Not Rated

Not Rated: Balaji Amines Ltd.

BP Wealth

Dominant player in the Indian amines industry The Indian aliphatic amines industry is largely a duopoly with Balaji Amines (BAL) and Alkyl Amines Chemicals comprising more than 90% of the market. Yet, the product portfolio of these two companies within the industry is varied with each being dominant in specific chemicals. This has made the industry structure appear closer to being a monopoly for each of the players with the key competition being, only imports. BAL manufactures amines (methyl amines and ethyl amines) and their derivatives, speciality chemicals and pharma excipients. Overall, the company has a portfolio of over 25 products, which are supplied to domestic and foreign players (exports accounted for around 21% of the total sales in...

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines Ltd.

28 Aug 2019

1411.40

-4.12%

Balaji Amines may gain on arm's strength

Business Line

Balaji Speciality Chemicals Pvt Ltd, subsidiary of Balaji Amines, has completed REACH Registration process for ethylenediamine. The registration woul

Number of FII/FPI investors decreased from 112 to 105 in Jun 2025 qtr

Balaji Amines Ltd.

30 Jul 2019

1411.40

-4.12%

Balaji Amines Ltd - Result Update Q1FY20

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines Ltd's (BAL) Q1FY20 results were lower than our estimates as the company was impacted by a slowdown in key end-user industries and volatility in prices of raw material.

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Balaji Amines Ltd.

29 Jul 2019

1411.40

-4.12%

Balaji Amines (1QFY20): Weak performance. Maintain BUY

Buy: Balaji Amines Ltd.

Target

HDFC Securities

Post an underwhelming Q1 and tepid volume outlook, we cut our EPS estimate by 11.4/14.5% for FY20/21E. Given the (1) Muted earnings growth prospects, (2) Declining return ratios (ROE: 14.6/14.4/13.1%, RoIC: 21.8/21.8/19.1% in FY20E/21E/22E), we prefer Alkyl Amines over Balaji in the Amines space. BAL reported muted performance in Q1FY20 consequential to (1) Soft volume off-take by the agrochemical industry, (2) High raw material prices, predominantly Methanol. Hence, we cut our EPS estimates for FY20/21 and arrive at a TP of Rs 452/share based on 13x Sep-21E EPS.

Balaji Amines Ltd. has lost -38.28% in the last 1 Year

Is Balaji Amines Ltd. worth buying?

384 Votes:

Buy 83.85%

Sell 9.38%

Hold 6.77%

40.55% Fall from 52W High

Balaji Amines Ltd. News and Updates

Keep track of all breaking news on Balaji Amines Ltd. from all sources in a single place.